Pular para o conteúdo
· Preenchimentos dérmicos
SKU 10481

HArmonyCa Lidocaine

Em stock
Volume
2 x 125 mL
Laboratório
Allergan Aesthetics
Origem
França
Indicação
Facial soft tissue augmentation; dual-action rejuvenation
O preço profissional e o histórico são exclusivos de contas verificadas
allpara fornece profissionais licenciados. Inicie sessão ou peça uma conta B2B para ver os preços em tempo real, os escalões por volume e o histórico de preços.

HArmonyCa Lidocaine is a hybrid hyaluronic acid and calcium hydroxyapatite injectable facial implant for the Allergan Aesthetics range, intended for facial soft tissue augmentation. It is suitable for authorised medical practitioners, who place it in the deep dermal and sub-dermal layers of the mid and lower face, where the hyaluronic acid provides an immediate lifting and volumising effect and the calcium hydroxyapatite microspheres support sustained collagen stimulation, so one treatment gives both an instant result and progressive structural support. The product contains calcium hydroxyapatite microspheres of 25 to 45 microns at 55.7%, cross-linked sodium hyaluronate gel at 20 mg/mL, phosphate buffer and lidocaine hydrochloride at 3 mg/mL (0.3%) to reduce pain during treatment, and it is a CE-marked medical device for professional use by authorised medical practitioners only. It is supplied as two 1.25 mL pre-filled glass syringes with two single-use 27G half-inch thin-wall sterile needles.

Principais vantagens de HArmonyCa Lidocaine

  • Provides an immediate lifting and volumising effect through hyaluronic acid
  • Supports sustained collagen stimulation through calcium hydroxyapatite
  • Combines hyaluronic acid and calcium hydroxyapatite in one ready-to-use injectable
  • Designed for facial soft tissue augmentation in the deep dermal and sub-dermal layers
  • Contains 0.3% lidocaine hydrochloride to reduce pain during treatment
  • Supplied as two 1.25 mL pre-filled syringes with two 27G thin-wall needles
  • CE-marked medical device
Informação essencial
Marca HARMONYCA
Fabricante Allergan Aesthetics
País de origem France
Certificação CE-marked medical device; filled syringe CE 2409, needle CE 0123
Composição Calcium hydroxyapatite microspheres 25-45 microns (55.7%); cross-linked sodium hyaluronate gel 20 mg/mL; phosphate buffer; lidocaine hydrochloride 3 mg/mL (0.3%)
Embalagem 2 pre-filled syringes x 1.25 mL, with 2 single-use 27G 1/2" thin-wall sterile needles
Tamanho da agulha 27G 1/2" thin-wall needles supplied; 25G or 27G thin-wall if a needle replacement is needed
Tipo de utilização Professional use only - sterile, biodegradable injectable facial implant; single use, single patient
Profundidade de injeção Deep dermal and sub-dermal layers

Indicações e utilização profissional

Principais indicações

  • Facial soft tissue augmentation
  • Deep dermal and sub-dermal facial volume augmentation

Utilização profissional

For use only by authorised medical practitioners in accordance with local regulation, under sterile conditions, following clinical assessment. Single use, single patient; do not re-sterilise. Insert at approximately 30 degrees into the deep dermis with the bevel oriented downwards, using a linear threading technique, and cross-hatching in layers where larger volumes are required. Aspirate before injecting. Subsequent treatments may be required, with at least seven days between treatments to allow evaluation of the outcome, and at least four weeks between ultrasound-based, laser or peeling treatments and use of this product. It is contraindicated in pregnancy or breastfeeding, in patients under 18, in patients with known sensitivity to any product component or to lidocaine or other amide-type local anaesthetics, and in patients with conditions for which lidocaine is contraindicated. It is also contraindicated in skin disease or abnormal skin conditions, acute or chronic infection or inflammation at or near the treatment site, susceptibility to keloid or hypertrophic scarring, impaired wound healing, prolonged bleeding, a history of anaphylaxis or multiple severe allergies, known sensitivity to steroids, herpes, and autoimmune disease. It must not be injected into the glabellar or periocular areas, the lips or perioral region, regions containing foreign bodies, blood vessels or highly vascularised areas, or the epidermis or superficial dermis.

Zonas de tratamento

  • Mid and lower face
  • Cheek lines
  • Lower-face contour and sagginess
  • Skin firmness

Perfil do paciente

Patients aged 18 years or older who are suitable for facial soft tissue augmentation following clinical assessment by an authorised medical practitioner. Contraindicated during pregnancy and breastfeeding, and in patients meeting the other exclusion criteria, including known sensitivity to any product component or to amide-type local anaesthetics. Safety and efficacy have not been evaluated in diabetic patients, in patients who previously received other filling implants, or in patients with a history of keloid formation, connective tissue disease, active bleeding disorders, active hepatitis, cancer, stroke or myocardial infarction, or on immunosuppressive therapy.

Como funciona HArmonyCa Lidocaine ​

HArmonyCa combines cross-linked hyaluronic acid and calcium hydroxyapatite in a single injectable. The hyaluronic acid component provides an immediate lifting and volumising effect, while the calcium hydroxyapatite microspheres, at 25 to 45 microns and 55.7% of the formulation, support sustained collagen stimulation and provide progressive structural support after treatment. The 0.3% lidocaine hydrochloride reduces pain during treatment. The implant is placed in the deep dermal and sub-dermal layers and is biodegradable.

Porquê encomendar na Allpara

A Allpara oferece produtos HARMONYCA originais e verificados de fornecedores selecionados, com rastreabilidade total dos lotes e apoio especializado. Servimos clínicas e profissionais de estética com produtos com certificação CE, entrega rápida em toda a UE a partir do nosso armazém na UE e preços profissionais competitivos. A nossa prioridade é a segurança, a satisfação e os resultados dos seus pacientes, com apoio pós-venda dedicado para a sua tranquilidade.

Perguntas frequentes

What is in HArmonyCa?

Calcium hydroxyapatite microspheres of 25 to 45 microns diameter at 55.7%, suspended in a cross-linked sodium hyaluronate gel at 20 mg/mL from a non-animal source, with a phosphate buffer and lidocaine hydrochloride at 3 mg/mL.

How does HArmonyCa differ from a standard hyaluronic acid filler?

HArmonyCa combines cross-linked hyaluronic acid for immediate volume with calcium hydroxyapatite microspheres for sustained collagen stimulation, giving it a dual mechanism that standard single-ingredient hyaluronic acid fillers do not have.

How often can HArmonyCa be repeated?

Subsequent treatments may be required to obtain optimal results, with at least seven days between treatments so the outcome of the implantation can be evaluated.

Mais de Allergan

Ver laboratório

Alternativas para a clínica

Todos os produtos
Gouri
Gouri Bioestimuladores de colagénio

HArmonyCa Lidocaine

Em stock
Marcação CE Marcação CE HArmonyCa Lidocaine
Preços exclusivos para contas verificadas
Inicie sessão ou peça uma conta B2B para ver o seu preço.
Pedir conta B2B

HArmonyCa Lidocaine is a hybrid hyaluronic acid and calcium hydroxyapatite injectable facial implant for the Allergan Aesthetics range, intended for facial soft tissue augmentation. It is suitable for authorised medical practitioners, who place it in the deep dermal and sub-dermal layers of the mid and lower face, where the hyaluronic acid provides an immediate lifting and volumising effect and the calcium hydroxyapatite microspheres support sustained collagen stimulation, so one treatment gives both an instant result and progressive structural support. The product contains calcium hydroxyapatite microspheres of 25 to 45 microns at 55.7%, cross-linked sodium hyaluronate gel at 20 mg/mL, phosphate buffer and lidocaine hydrochloride at 3 mg/mL (0.3%) to reduce pain during treatment, and it is a CE-marked medical device for professional use by authorised medical practitioners only. It is supplied as two 1.25 mL pre-filled glass syringes with two single-use 27G half-inch thin-wall sterile needles.

Principais vantagens de HArmonyCa Lidocaine

  • Provides an immediate lifting and volumising effect through hyaluronic acid
  • Supports sustained collagen stimulation through calcium hydroxyapatite
  • Combines hyaluronic acid and calcium hydroxyapatite in one ready-to-use injectable
  • Designed for facial soft tissue augmentation in the deep dermal and sub-dermal layers
  • Contains 0.3% lidocaine hydrochloride to reduce pain during treatment
  • Supplied as two 1.25 mL pre-filled syringes with two 27G thin-wall needles
  • CE-marked medical device
Informação essencial
Marca HARMONYCA
Fabricante Allergan Aesthetics
País de origem France
Certificação CE-marked medical device; filled syringe CE 2409, needle CE 0123
Composição Calcium hydroxyapatite microspheres 25-45 microns (55.7%); cross-linked sodium hyaluronate gel 20 mg/mL; phosphate buffer; lidocaine hydrochloride 3 mg/mL (0.3%)
Embalagem 2 pre-filled syringes x 1.25 mL, with 2 single-use 27G 1/2" thin-wall sterile needles
Tamanho da agulha 27G 1/2" thin-wall needles supplied; 25G or 27G thin-wall if a needle replacement is needed
Tipo de utilização Professional use only - sterile, biodegradable injectable facial implant; single use, single patient
Profundidade de injeção Deep dermal and sub-dermal layers

Indicações e utilização profissional

Principais indicações

  • Facial soft tissue augmentation
  • Deep dermal and sub-dermal facial volume augmentation

Utilização profissional

For use only by authorised medical practitioners in accordance with local regulation, under sterile conditions, following clinical assessment. Single use, single patient; do not re-sterilise. Insert at approximately 30 degrees into the deep dermis with the bevel oriented downwards, using a linear threading technique, and cross-hatching in layers where larger volumes are required. Aspirate before injecting. Subsequent treatments may be required, with at least seven days between treatments to allow evaluation of the outcome, and at least four weeks between ultrasound-based, laser or peeling treatments and use of this product. It is contraindicated in pregnancy or breastfeeding, in patients under 18, in patients with known sensitivity to any product component or to lidocaine or other amide-type local anaesthetics, and in patients with conditions for which lidocaine is contraindicated. It is also contraindicated in skin disease or abnormal skin conditions, acute or chronic infection or inflammation at or near the treatment site, susceptibility to keloid or hypertrophic scarring, impaired wound healing, prolonged bleeding, a history of anaphylaxis or multiple severe allergies, known sensitivity to steroids, herpes, and autoimmune disease. It must not be injected into the glabellar or periocular areas, the lips or perioral region, regions containing foreign bodies, blood vessels or highly vascularised areas, or the epidermis or superficial dermis.

Zonas de tratamento

  • Mid and lower face
  • Cheek lines
  • Lower-face contour and sagginess
  • Skin firmness

Perfil do paciente

Patients aged 18 years or older who are suitable for facial soft tissue augmentation following clinical assessment by an authorised medical practitioner. Contraindicated during pregnancy and breastfeeding, and in patients meeting the other exclusion criteria, including known sensitivity to any product component or to amide-type local anaesthetics. Safety and efficacy have not been evaluated in diabetic patients, in patients who previously received other filling implants, or in patients with a history of keloid formation, connective tissue disease, active bleeding disorders, active hepatitis, cancer, stroke or myocardial infarction, or on immunosuppressive therapy.

Como funciona HArmonyCa Lidocaine ​

HArmonyCa combines cross-linked hyaluronic acid and calcium hydroxyapatite in a single injectable. The hyaluronic acid component provides an immediate lifting and volumising effect, while the calcium hydroxyapatite microspheres, at 25 to 45 microns and 55.7% of the formulation, support sustained collagen stimulation and provide progressive structural support after treatment. The 0.3% lidocaine hydrochloride reduces pain during treatment. The implant is placed in the deep dermal and sub-dermal layers and is biodegradable.

Porquê encomendar na Allpara

A Allpara oferece produtos HARMONYCA originais e verificados, com rastreabilidade total dos lotes, stock com certificação CE, entrega rápida em toda a UE e apoio pós-venda especializado.

Perguntas frequentes

What is in HArmonyCa?

Calcium hydroxyapatite microspheres of 25 to 45 microns diameter at 55.7%, suspended in a cross-linked sodium hyaluronate gel at 20 mg/mL from a non-animal source, with a phosphate buffer and lidocaine hydrochloride at 3 mg/mL.

How does HArmonyCa differ from a standard hyaluronic acid filler?

HArmonyCa combines cross-linked hyaluronic acid for immediate volume with calcium hydroxyapatite microspheres for sustained collagen stimulation, giving it a dual mechanism that standard single-ingredient hyaluronic acid fillers do not have.

How often can HArmonyCa be repeated?

Subsequent treatments may be required to obtain optimal results, with at least seven days between treatments so the outcome of the implantation can be evaluated.

Mais de Allergan

Ver o laboratório →
* Produto de uso profissional. A embalagem pode variar consoante o lote ou o mercado. Consulte as instruções de utilização fornecidas para as indicações completas e as contraindicações.